| 9651543 |
Malaria antigen screening method |
Joseph T. Bruder, Imre Kovesdi, Duncan McVey, C. Richter King, Denise Louise Doolan +5 more |
2017-05-16 |
|
| 9629906 |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
Duncan McVey, Jason G. D. Gall |
2017-04-25 |
$428,000 |
| 9617560 |
Simian (gorilla) adenovirus or adenoviral vectors and methods of use |
Jason G. D. Gall, Duncan McVey |
2017-04-11 |
$414,000 |
| 9586998 |
Methods of propagating monkey adenoviral vectors |
Jason G. D. Gall, Christoph Kahl, Duncan McVey |
2017-03-07 |
$525,000 |
| 9580476 |
Adenoviral vector-based respiratory syncytial virus (RSV) vaccine |
Jason G. D. Gall, Duncan McVey |
2017-02-28 |
$539,000 |
| 9388429 |
Method for propagating adenoviral vectors encoding inhibitory gene products |
Jason G. D. Gall, C. Richter King |
2016-07-12 |
$387,000 |
| 9233153 |
Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
Jason G. D. Gall, Duncan McVey |
2016-01-12 |
$257,000 |
| 9133248 |
Methods of propagating monkey adenoviral vectors |
Jason G. D. Gall, Christoph Kahl, Duncan McVey |
2015-09-15 |
$749,000 |
| 8920813 |
Adenoviral vector-based dengue fever vaccine |
Joseph T. Bruder, Duncan McVey |
2014-12-30 |
$619,000 |
| 8450055 |
Malaria antigen screening method |
Joseph T. Bruder, Imre Kovesdi, Duncan McVey, C. Richter King, Denise Louise Doolan +5 more |
2013-05-28 |
|
| 8323663 |
Adenoviral vector-based foot-and-mouth disease vaccine |
Joseph T. Bruder, C. Richter King, Marvin J. Grubman, John Neilan |
2012-12-04 |
$196,000 |
| 7195896 |
Complementary adenoviral vector systems and cell lines |
Imre Kovesdi, Duncan McVey, Joseph T. Bruder, Alena Lizonova |
2007-03-27 |
$3,784,000 |
| 7070930 |
Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
Duncan McVey, Mohammed Zuber, Imre Kovesdi |
2006-07-04 |
|
| 6998263 |
Methods of preparing and using a viral vector library |
Imre Kovesdi, Duncan McVey, Thomas Wickham, Joseph T. Bruder |
2006-02-14 |
$1,615,000 |
| 6951755 |
Vectors and methods for gene transfer |
Thomas Wickham, Imre Kovesdi |
2005-10-04 |
$2,382,000 |
| 6913927 |
Non-adenoviral gene product-based complementing cells for adenoviral vectors |
Jason G. D. Gall, Imre Kovesdi |
2005-07-05 |
$1,756,000 |
| 6821775 |
Viral vector encoding pigment epithelium-derived factor |
Imre Kovesdi, Duncan McVey, Lisa Wei |
2004-11-23 |
$1,846,000 |
| 6682929 |
Adenovector complementing cells |
Jason G. D. Gall, Imre Kovesdi |
2004-01-27 |
$5,331,000 |
| 6677156 |
Non-adenoviral gene product-based complementing cells for adenoviral vectors |
Jason G. D. Gall, Imre Kovesdi |
2004-01-13 |
$4,488,000 |
| 6660521 |
Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus |
Imre Kovesdi |
2003-12-09 |
$4,871,000 |
| 6649373 |
Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene |
Imre Kovesdi |
2003-11-18 |
$2,876,000 |
| 6579522 |
Replication deficient adenoviral TNF vector |
C. Richter King, Imre Kovesdi, Jasper J. Schaible |
2003-06-17 |
$1,900,000 |
| 6482616 |
RCA-free adenoviral vector system and propagation method |
Imre Kovesdi, Duncan McVey, Joseph T. Bruder, Alena Lizonova |
2002-11-19 |
$1,401,000 |
| 6475757 |
Plasmids for construction of eukaryotic viral vectors |
Duncan McVey, Imre Kovesdi |
2002-11-05 |
$1,071,000 |
| 6465253 |
Vectors and methods for gene transfer to cells |
Thomas Wickham, Imre Kovesdi |
2002-10-15 |
$1,238,000 |